Cartiere Carrara Buys Tissue Converters Carind and CRC
Print this Article | Send to Colleague
Italy’s Cartiere Carrara has acquired tissue converters Carind and CRC, thus creating Gruppo Cartiere Carrara.
With the acquisition of the two companies, which are active in the consumer and away-from - home (AfH) segments, Cartiere Carrara aims at enhancing its offering in the high-quality AfH market, which has strong growth potential, and reinforcing its presence in the Italian consumer market. The firm will bolster this effort via an ad-hoc multi-year investment plan for the acquired firms.
“This deal fits perfectly with our M&A guidelines, which are focused on outstanding companies that could be integrated in our production and commercial structure, thus making it more distinct from a quality and sustainability point of view,” Cartiere Cararra chief growth officer Mario Carrara commented.
Elsewhere, the company invested Euro 17 million ($18.8 million) in a new tissue line and cogeneration plant at its Carma Ferrania mill in Cairo Montenotte. The new production line is expected to ramp-up in the second half of the year, will use paper for recycling as a raw material and will have a production capacity of 40,000 mtpy. The cogeneration plant will have an electrical capacity of 4.2 MW/yr.
Cartiere Carrara is both a producer and a converter of tissue paper. It produces approximately 240,000 mtpy of paper on eight paper machines. It has a total of six production sites and 35 converting lines. Back to Tissue360 Newsletter |